AML xenograft efficiency is significantly improved in NOD SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3 von Wunderlich, M, Chou, F-S, Link, K A, Mizukawa, B, Perry, R L, Carroll, M, Mulloy, J C

Volltext

Posttranslational modifications of RUNX1 as potential anticancer targets von Goyama, S, Huang, G, Kurokawa, M, Mulloy, J C

Volltext

UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO von Goyama, S, Schibler, J, Gasilina, A, Shrestha, M, Lin, S, Link, K A, Chen, J, Whitman, S P, Bloomfield, C D, Nicolet, D, Assi, S A, Ptasinska, A, Heidenreich, O, Bonifer, C, Kitamura, T, Nassar, N N, Mulloy, J C

Volltext

CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors von Negrotto, S, Ng, K P, Jankowska, A M, Bodo, J, Gopalan, B, Guinta, K, Mulloy, J C, Hsi, E, Maciejewski, J, Saunthararajah, Y

Volltext

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia von Ng, K P, Ebrahem, Q, Negrotto, S, Mahfouz, R Z, Link, K A, Hu, Z, Gu, X, Advani, A, Kalaycio, M, Sobecks, R, Sekeres, M, Copelan, E, Radivoyevitch, T, Maciejewski, J, Mulloy, J C, Saunthararajah, Y

Volltext

Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs von Maiques-Diaz, A, Chou, F S, Wunderlich, M, Gómez-López, G, Jacinto, F V, Rodriguez-Perales, S, Larrayoz, M J, Calasanz, M J, Mulloy, J C, Cigudosa, J C, Alvarez, S

Volltext

The HTLV-I orfI Protein Is Recognized by Serum Antibodies from Naturally Infected Humans and Experimentally Infected Rabbits von Dekaban, G.A., Peters, A.A., Mulloy, J.C., Johnson, J.M., Trovato, R., Rivadeneira, E., Franchini, G.

Volltext